The data privacy settings of your browser prevent this site from functioning properly. Please open the site in a new tab. Alternatively, you can allow cross-sitetracking in your browser.
Open in new tab

Join AiCuris


AiCuris - founded in 2006 - is a specialist for infectious diseases. Its focus comprises discovery, research and development of novel antiviral and antibacterial agents in the indications Human Cytomegalovirus, Herpes simplex, Hepatitis B, and (multi)resistant bacterial infections treated in the hospital. With its highly innovative Pipeline, AiCuris addresses specialist markets and severe, potentially life-threatening infections with high medical need. A major step for the company was the marketing authorization for Prevymis™ (Letermovir) in the US and Europe.

You can find an image film about AiCuris here.


Search Simple search